alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Order entered January 1 2 , 2018

In The 

## Court of Appeals Fifth District of Texas at Dallas

No. 05
- 17
- 01294
- CV
IN THE INTEREST OF S .V. AND S.V., CHILDR EN On Appeal from the 255th Judicial District Co urt

Dallas County, Texas Trial Court Cause No. DF
- 04
- 11968
- V



### O RDER Before Chief Justice Wright, Justice Francis, and Justice Stoddart Before the Court is the December 18, 2017 motion of Coppell Independent School District to dismiss appellant’s amended n otice of appeal. We DENY the motion. On the Court’s own motion, we construe the amended notice of appeal as a notice of appeal and DIRECT the Clerk of this Court assign a new appellate cause number to the notice of appeal filed in this appeal on Novembe r 29, 2017. In the notice of appeal, appellant states he is appealing from the modification order in the suit affecting the parent

- child relationship signed on October 20, 2017. A notice of appeal from that order was due on Monday, November 20, 2017. See T EX
. R. A PP
. P. 26.1. Appellant filed the notice of appeal, nine days past the deadline. However, because the notice of appeal was filed within fifteen days of the deadline, appellant can remedy the timeliness problem by filing, by January 22, 2017 , a motion for extension of time that complies with rule of appellateprocedure 10.5(b). See T EX
. R. A PP
. P. 26.3, 10.5(b). We caution appellant that failure to file an

extension motion within the time specified may result i n dismissal of the appeal in the newly assigned appellate cause number without further notice.
/s/ CAROLYN WRIGHT CHIEF JUSTICE
# Iris Oifigiúill C NaN/2011

| | ISSN 1725-2571
  doi:10.3000/17252571.CA2011.068.gla |
| --- | --- |
| Iris Oifigiúill
  an Aontais Eorpaigh | C NaN |
| | |
| An t-eagrán Gaeilge | Faisnéis agus Fógraí | 543 Márta 2011 |

ISSN 1725-2571

doi:10.3000/17252571.CA2011.068.gla

Iris Oifigiúill

an Aontais Eorpaigh

C NaN

An t-eagrán Gaeilge

Faisnéis agus Fógraí

543 Márta 2011

---

| | Clár | Leathanach |
| --- | --- | --- |
| | Ceartúchán |
| 2011/C /01 | Ceartúchán ar an bhfógra comórtas oscailte EPSO/AST/112/10 — Cúntóirí (AST 3) (IO C 341 A, 16.12.2010)
  (Iris Oifigiúil an Aontais Eorpaigh Eagrán Speisialta Gaeilge) | 1 |

Clár

Leathanach

Ceartúchán

2011/C /01

Ceartúchán ar an bhfógra comórtas oscailte EPSO/AST/112/10 — Cúntóirí (AST 3) (IO C 341 A, 16.12.2010)
  (Iris Oifigiúil an Aontais Eorpaigh Eagrán Speisialta Gaeilge)

(IO C 341 A, 16.12.2010)

(Iris Oifigiúil an Aontais Eorpaigh Eagrán Speisialta Gaeilge)

1

ATHBHREITHNIÚ AR IRISÍ OIFIGIÚLA C A COMÓRTAS

Anseo thíos gheobhaidh tú liosta de na heagráin C A a foilsíodh le linn na bliana reatha.

Mura gcuirtear a mhalairt in iúl, foilsítear leagan den IO i ngach teanga.

| 19 | (PL) |
| --- | --- |
| 24 | |
| 35 | (DE/EN/FR) |
| 37 | (PL/RO) |
| 60 | |
| 68 | |

19

(PL)

24

35

(DE/EN/FR)

37

(PL/RO)

60

68

| | |
| --- | --- |
| | (1)   Faoin tagairt C 68 A a foilsíodh ábhar an eagráin seo i dteangacha oifigiúla eile an Aontais Eorpaigh. |

---

(1)   Faoin tagairt C 68 A a foilsíodh ábhar an eagráin seo i dteangacha oifigiúla eile an Aontais Eorpaigh.

1

| GA | |
| --- | --- |

GA

---

Ceartúchán

| 3.3.2011 | GA | Iris Oifigiúill an Aontais Eorpaigh | C NaN/1 |
| --- | --- | --- | --- |

3.3.2011

GA

Iris Oifigiúill an Aontais Eorpaigh

C NaN/1

---

Ceartúchán ar an bhfógra comórtas oscailte EPSO/AST/112/10 — Cúntóirí (AST 3)

(
  Iris Oifigiúil an Aontais Eorpaigh C 341 A an 16 Nollag 2010
  )

(Iris Oifigiúil an Aontais Eorpaigh Eagrán Speisialta Gaeilge)

(2011/C 68 A/01)

Leathanach 3, Roinn IV, pointe 2:

In ionad:

| “Triail d) | scileanna gairme:


  cruinneas agus beachtas | marcáil: 0-20 pointe


  pasmharc: 10 bpointe |
| --- | --- | --- |
| Triail e) | scileanna gairme:


  cinneadh tosaíochtaí agus eagrúchán | marcáil: 0-20 pointe


  pasmharc: 10 bpointe” |

“Triail d)

scileanna gairme:

cruinneas agus beachtas

marcáil: 0-20 pointe

pasmharc: 10 bpointe

Triail e)

scileanna gairme:

cinneadh tosaíochtaí agus eagrúchán

marcáil: 0-20 pointe

pasmharc: 10 bpointe”

Léitear:

| “Triail d) | scileanna gairme:


  cruinneas agus beachtas | marcáil: 0-20 pointe |
| --- | --- | --- |
| Triail e) | scileanna gairme:


  cinneadh tosaíochtaí agus eagrúchán | marcáil: 0-20 pointe |
| | Is é an pasmharc 20 bpointe as triail d) agus triail e) le chéile” |

“Triail d)

scileanna gairme:

cruinneas agus beachtas

marcáil: 0-20 pointe

Triail e)

scileanna gairme:

cinneadh tosaíochtaí agus eagrúchán

marcáil: 0-20 pointe

Is é an pasmharc 20 bpointe as triail d) agus triail e) le chéile”

---
<PAGE>

EXHIBIT 32.2

                  CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
      PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906
                        OF THE SARBANES-OXLEY ACT OF 2002

The undersigned hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and in connection with
this quarterly report on Form 10-Q, that:

     -    the report fully complies with the requirements of Sections 13(a) and
          15(d) of the Securities and Exchange Act of 1934, as amended, and

     -    the information contained in the report fairly presents, in all
          material respects, the Corporation's financial condition and results
          of operations of the corporation as of the dates and for the periods
          expressed in this quarterly report.


/s/ Kevin A. Schmidt
Kevin A. Schmidt,
Principal Financial Officer

Dated: August 13, 2007


                                       28
###### Editorial Note on Part 21

#### Editorial Notes:

1. For miscellaneous amendments to cross references in this 21 see Amdt. 21-10, 31 FR 9211, July 6, 1966.

2. Nomenclature changes to part 21 appear at 74 FR 53384, Oct. 16, 2009.

#### § 21.173 Eligibility.

Any registered owner of a U.S.-registered aircraft (or the agent of the owner) may apply for an airworthiness certificate for that aircraft. An application for an airworthiness certificate must be made in a form and manner acceptable to the FAA, and may be submitted to any FAA office.

[Amdt. 21-26, 34 FR 15244, Sept. 30, 1969]
ARCADIA RESOURCES, INC.  BOARD OF DIRECTOR COMPENSATION  FOR OCTOBER 1, 2008 TO SEPTEMBER 30, 2009
  Annual Board Retainer (Per Director):
    
    $
    25,000Board Meeting Fee (Per Director Per Meeting)
    
    $
    1,500Annual Committee Chair Retainers: Audit Committee Chair
    
    $
    15,000 Compensation Committee Chair
    
    $
    10,000 Nominating & Governance Committee Chair
    
    $
    10,000Annual Audit Committee Member Retainer (Per Member):
    
    $
    5,000Committee Meeting Fee (Per Director Per Meeting)
    
    $
    1,000Compensation for Meetings on Special Matters (One Time Payment Per Director)
    
    $
    5,000Reimbursement for Travel Expenses:
    
    As Incurred
  
    
    Forty percent (40%) of the compensation will be payable in options to purchase shares of the Companys common stock, with the number of options to be granted
determined by the Black-Sholes or other modeling technique. Options will vest
quarterly and are subject to forfeiture per existing director compensation
agreements.
    
    Sixty percent (60%) of the compensation will be payable in cash. The cash will
be paid in two equal installments on March 31, 2009 and September 30, 2009.
exv10w2






Exhibit 10.2




Confidential Materials omitted and filed separately with the

Securities and Exchange Commission. Asterisks denote omissions.




AMENDMENT NO. 3 TO

AMENDED AND RESTATED DISTRIBUTION AGREEMENT




     This is Amendment No. 3 (this “Amendment”) to the Amended and Restated Distribution Agreement,
effective as of February 28, 2007, between The Medicines Company, a Delaware corporation with
offices at 8 Campus Drive, Parsippany, NJ 07054 (“TMC”), and Integrated Commercialization
Solutions, Inc., a California corporation with offices at 3101 Gaylord Parkway, Frisco, TX 75034
(the “Distributor”). This Amendment is effective as of August 12, 2009 (the “Effective Date”).



Recitals




     WHEREAS, TMC and Distributor are parties to the Amended and Restated Distribution Agreement,
dated February 28, 2007, as amended by Amendment No. 1 dated November 7, 2007 and Amendment No. 2
dated October 1, 2008 (as amended, the “Agreement”), under which Distributor distributes TMC’s
products ANGIOMAX® (bivalirudin) and Cleviprex® (clevidipine butyrate).; and



     WHEREAS, the parties now desire to amend the Agreement as more fully set forth herein;



     NOW, THEREFORE, in consideration of the premises and the covenants and agreements contained
herein, and for other good and valuable consideration, the receipt of which are hereby
acknowledged, the parties agree as follows:



     1. Defined Terms. Capitalized terms that are not defined in this Amendment shall have
the meanings given to them in the Agreement.



     2. Payment by Distributor for Product Orders. Section 5.1 of the Agreement is deleted
in its entirety and replaced with the following:




Payment by Distributor for Product Orders. Distributor agrees to pay for
each Product unit based on the purchase price schedule in Exhibit B, which may be
amended from time to time at TMC’s sale discretion. Distributor’s terms of payment
shall be (a) [**]. Should TMC discontinue the Drop Ship Channel and implement a
Direct Channel model for all customers, the [**]%/30 days terms will be discontinued
to the Distributor. Distributor shall be entitled to four (4) float days for all
payments made by electronic fund transfers to the TMC lockbox account.




	 	Account Name:	 	 The Medicines Company
	 
	 	Bank Name:	 	 JP Morgan Chase Bank

New York, NY 01004
	 
	 	Account No.:	 	 [**]
	 
	 	FED ABA No.:	 	 [**]




3. Effect of Amendment. Except as expressly provided in this Amendment, the Agreement will
continue in full force according to its terms. If there is any conflict between the Agreement and
any provision of this Amendment, this Amendment will control.




 









 









     IN WITNESS WHEREOF, the parties have executed this Amendment as of the Effective Date.



	 	 	 	 	 	 	 	 	 
	The Medicines Company	 	 	 	Integrated Commercialization Solutions, Inc.
	 
	 	 	 	 	 	 	 	 
	By:

	 	/s/ John F. Riggs
	 	 	 	By:
	 	/s/ Doug Cook
	 

	 	 
	 	 	 	 	 	 
	Name:

	 	John F. Riggs
	 	 	 	Name:
	 	Doug Cook
	Title:

	 	VP Global Contracting & Pricing
Integrity
	 	 	 	Title:
	 	VP, Distribution Services
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1000
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-END>                               JUN-30-1997
<CASH>                                            1403
<SECURITIES>                                         0
<RECEIVABLES>                                        6
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                  1409
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                    1409
<CURRENT-LIABILITIES>                               18
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                        1391
<TOTAL-LIABILITY-AND-EQUITY>                      1409
<SALES>                                              0
<TOTAL-REVENUES>                                    33
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                    56
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                   (23)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                               (23)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                      (23)
<EPS-PRIMARY>                                   (0.01)
<EPS-DILUTED>                                   (0.01)
        

</TABLE>
AFFIRM; Opinion Filed November 14, 2012

In The 

## Qlourtofppcat 

# ififtj 

## OttrictofZJtcxa at

## Oafta No. 05-12-00591-CR No. 05-12-00592-CR BRUCE KEVIN CONWAY, Appellant V. THE STATE OF TEXAS, Appellee On Appeal from the 194th Judicial District Court Dallas County, Texas ________

Trial Court Cause Nos. F07-57835-M, F10-61538-M MEMORANDUM OPINION Before Justices ONei11, FitzGerald, and Lang-Miers Opinion by Justice FitzGerald Bruce Kevin Conway was convicted ofpossession with intent to deliver cocaine in an amount of four grams or more but less than 200 grams and possession with intent to deliver cocaine in an amount ofone gram or more but less than four grams. Punishmentwas assessed in the first case at ten years’ imprisonment. Punishment was assessed in the second case at ten years’ imprisonment and a $2,000 fine. We adopted the trial court’s finding that appellant no longer desires to pursue the appeals and we ordered the appeals submitted without briefs. See TEx. R. App. P. 38.8(b)(4). Absentbriefs no issues are before us.CCoCCCZvm

# / ?


## Qrourt of Ztppeat 

## jfiftj ttrict of exa at at1a JUDGMENT BRUCE KEVIN CONWAY. Appellant Appeal from the 194th Judicial District Court ofDallas County, Texas (Tr.Ct.No. No. O5l2-OO59 1-CR V. F07-57835-M). Opinion delivered by Justice FitzGerald. TIlE STATE OF TEXAS, Appellee Justices O’Neill and Lang-Miers participating. Based on the Court’s opinion ofthis date, we AFFiRM the trial court’s judgment.
Judgment entered November 14, 2012.

- KERRY P. Fl FZGFRAI 1) .Jt 1 STI( F

## ififtj 

## Oitrittof 1texaat atta JUDGMENT BRUCE KEVIN CONWAY. Appellant No. 05-12-00592-CR V. Ti-IF STATE OF TEXAS, Appellee Appeal from the 194th Judicial District Court ofDallas County. Texas (Tr.C’t.No. F 10-61 538-M). Opinion delivered by Justice FitzGerald, Justices O’Neill and Lang-Miers participating. Based on the Court’s opinion ofthis date, we AFFIRM the trial court’sjudgment.
Judgment entered November 14. 2012. 

## Qlourtof 1pptat
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Environmental Protection Agency

          - [ER-FRL-6353-9] 

Availability of EPA comments prepared April 17, 2000 through April 21, 2000 pursuant to the Environmental Review Process (ERP), under Section 309 of the Clean Air Act and section 102(2)(c) of the National Environmental Policy Act as amended. Requests for copies of EPA comments can be directed to the Office of Federal Activities at (202) 564-7167. 

An explanation of the ratings assigned to draft environmental impact statements (EISs) was published in FR dated April 09, 1999 (63 FR 17856). 

## Draft EISs 

ERP No. D-DOE-E09806-TN Rating EC2, Treating Transuranic (TRU)/Alpha Low-Level Waste at the Oak Ridge National Laboratory, Construct, Operate, and Decontaminate/Decommission of Waste Treatment Facility, Oak Ridge, TN. 

*Summary:*                     EPA expressed environmental concerns regarding the issue of process releases and the resulting risk to humans. EPA requested that additional information be provide on the risk issue and the preferred alternative.                 

ERP No. D-TVA-E65054-TN Rating EC2, Tellico Reservoir Land Management Plan, Implementation of Seven Mainstream and Two Tributary Reservoirs, Blount, Loudon and Monroe, TN. 

*Summary:*                     EPA expressed concerns with aspects of some of the proposed zones, such as planned timber harvesting and certain commercial/industrial development. EPA suggested that the Plan be revised to eliminate or minimize timber harvesting of circumferential reservoir lands and islands and eliminate incompatible forms of commercial and industrial development.                 

## Final EISs 

ERP No. F-BIA-A65165-00 Programmatic EIS—Navajo Ten Year Forest Management Plan Alternatives, Implementation and Funding, AZ and NM. 

*Summary:*                     No formal comment letter was sent to the preparing agency.                 

Dated: May 2, 2000 

Joseph C. Montgomery, 

Director, NEPA Compliance Director, Office of Federal Activities. 

[FR Doc. 00-11308 Filed 5-4-00; 8:45 am] 

BILLING CODE 6560-50-U
TEFLON® is a registered Trademark of the DuPont Company used under license by TORAY FLUOROFIBERS (AMERICA), Inc.

Visit us at WWW.TORAYFLUOROFIBERS.COM 

### Toray Fluorofibers (America), Inc. 2032 Highway 20 Decatur, AL 35601 Thursday, July 19, 2012

Mr. Toni Krasnic United States Environmental Protection Agency

Office of Pollution Prevention & Toxics

Chemical Control Division 1200 Penn Avenue, NW (MC 7405M) Washington, DC 20460

Dear Toni:

I would like to provide additional information about the Chinese fluoropolymer offerings being made to us. As I explained in my letter dated February 3, 2012 , we have received numerous offers to buy Chinese manufactured dispersions at prices significantly below the market price for PTFE dispersions from manufactures that have signed the 2010/2015 Voluntary Stewardship Program. Please find our correspondence with the vendor attached.

We elected to buy a small sample from one of the vendors for our evaluation. As part of the evaluation, we

asked them the PFOA content and were told that it was so low as to be barely detectible. We submitted the sample for evaluation and found that it contained between 3200 and 3700 PPM! I am attaching the test report for your review.

These materials and articles made from them are being offered in the US at prices that reflect the lower manufacturing cost of not complying with the Voluntary Stewardship Program. I know that the current plan is to issue regulations for these materials in Janu ary 2016. Unfortunately, this is creating a burden for Companies like TFA who have complied with the EPA’s request to phase out the use of PFOA early. I would like to encourage you to issue a SNUR for imported fluoropolymers and articles manufactured from them as quickly as possible. Concerning the articles to be covered I would suggest: Fluoropolymer fibers (continuous and Staple), PTFE/Fluoropolymer felts, filter bags made from PTFE/Fluoropolymer felts, Yarns for braiding, Mechanical Packings and other coated products where th e coating is either a fluoropolymer dispersion or a fluoropolymer membrane where the fluoropolymer source is China or

Taiwan.

Obviously, these articles should be allowed, if it is demonstrated that they are made from compliant polymers, however, as our own corr espondence demonstrates the vendor’s word cannot be accepted on face value. As a part of the SNUR, I would suggest that testing for PFOA should be required on a representative sample of the product or articles to be imported and should be borne by the importer of

record.

Finally, it has been brought to my attention that Senate Bill 2874 is requesting the elimination of the Duty on fabric laminates with PTFE membranes for apparel. Again, given the fact that these are likely sourced from China and are releasing considerable amounts of PFOA into the environment would you please notify the Department of Commerce of your opposition to this bill?

Sincerely,

Arthur R. Nelson

President & CEO
Exhibit 32.1





CERTIFICATION PURSUANT TO 8 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002








In connection with the Quarterly Report of American Rare Earths and Materials, Corp. (the "Registrant") on Form 10-Q for the quarter ended March 31, 2011, as filed with the Securities and Exchange Commission on the date hereof, I, Nataliya Hearn, Ph.D., President and Chief Executive Officer, and Principal Executive Officer of the Registrant, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and belief:





(1) The Quarterly Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and





(2) The information contained in the Quarterly Report fairly presents, in all material respects, the financial condition and result of operations of the Registrant.





A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.





Date:  May 13, 2011
By:
/s/ Nataliya Hearn, Ph.D.President Director and Principal Executive Officer
EXHIBIT 32.1



SECTION 906 CERTIFICATION



The following statement is provided by the undersigned to accompany the annual report on Form 10-K for the year ended December 31, 2003 pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350) and shall not be deemed filed pursuant to any provision of the Securities Exchange Act of 1934 or any other securities law.



Each of the undersigned certifies that the foregoing annual report on Form 10-K fully complies with the requirements of
Section 13(a) of the Securities Exchange Act of 1934 (15 U.S.C. 78m) and that the information contained in this annual report on Form 10-K fairly presents, in all material respects, the financial condition and results of operations of Corvis
Corporation.



|                   |  |                                                               |  |                      |  |          |  |                                                             
|------------------ |  | ------------------------------------------------------------- |  | -------------------- |  | -------- |  | ------------------------------------------------------------
|/s/ DAVID R. HUBER |  |                                                               |  | /s/ LYNN D. ANDERSON
|Name:              |  | David R. Huber                                                |  |                      |  | Name:    |  | Lynn D. Anderson                                            
|Title:             |  | Chairman of the Board, President, and Chief Executive Officer |  |                      |  | Title:   |  | Senior Vice President, Chief Financial Officer and Treasurer
|                   |  |                                                               |  |                     
|Company:           |  | Corvis Corporation                                            |  |                      |  | Company: |  | Corvis Corporation                                          
|                   |  |                                                               |  |                     
|Date:              |  | March 12, 2004                                                |  |                      |  | Date:    |  | March 12, 2004